Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.980
+0.090 (3.11%)
At close: Aug 25, 2026, 4:00 PM EDT
2.970
-0.010 (-0.34%)
After-hours: Aug 25, 2026, 7:16 PM EDT
Neuronetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 155.1 | 149.16 | 74.89 | 71.35 | 65.21 | 55.31 | |
Revenue Growth | 39.59% | 99.17% | 4.96% | 9.42% | 17.89% | 12.32% |
Cost of Revenue | 78.51 | 76.45 | 20.13 | 17.74 | 15.48 | 11.65 |
Gross Profit | 76.59 | 72.71 | 54.76 | 53.61 | 49.72 | 43.66 |
Selling, General & Admin | 93.18 | 97.16 | 75.95 | 72.74 | 75.5 | 63.3 |
Research & Development | 5.87 | 6.58 | 12.77 | 9.52 | 9.34 | 7.92 |
Operating Expenses | 99.05 | 103.74 | 88.72 | 82.26 | 84.83 | 71.22 |
Operating Income | -22.46 | -31.04 | -33.96 | -28.65 | -35.11 | -27.56 |
Interest Expense | -8.92 | -8.42 | -7.29 | -5.42 | -4.25 | -4.02 |
Interest & Investment Income | 1.46 | 0.72 | 2.55 | 5.79 | 2.2 | 0.2 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 0.19 |
EBT Excluding Unusual Items | -29.91 | -38.74 | -38.7 | -28.29 | -37.16 | -31.19 |
Asset Writedown | -0.4 | -0.4 | -0.6 | -1.9 | - | - |
Other Unusual Items | -0.54 | - | -4.43 | - | - | - |
Pretax Income | -30.85 | -39.14 | -43.73 | -30.19 | -37.16 | -31.19 |
Earnings From Continuing Operations | -30.85 | -39.14 | -43.73 | -30.19 | -37.16 | -31.19 |
Minority Interest in Earnings | 0.42 | 0.14 | 0.02 | - | - | - |
Net Income | -30.43 | -39 | -43.71 | -30.19 | -37.16 | -31.19 |
Net Income to Common | -30.43 | -39 | -43.71 | -30.19 | -37.16 | -31.19 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 70 | 66 | 32 | 29 | 27 | 25 |
Shares Outstanding (Diluted) | 70 | 66 | 32 | 29 | 27 | 25 |
Shares Change | 42.95% | 107.82% | 10.73% | 6.54% | 5.58% | 35.27% |
EPS (Basic) | -0.44 | -0.59 | -1.38 | -1.05 | -1.38 | -1.22 |
EPS (Diluted) | -0.44 | -0.59 | -1.38 | -1.05 | -1.38 | -1.22 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -11.25 | -21.18 | -32.46 | -34.41 | -34.01 | -30.34 |
Free Cash Flow Per Share | -0.16 | -0.32 | -1.02 | -1.20 | -1.26 | -1.19 |
Gross Margin | 49.38% | 48.75% | 73.12% | 75.13% | 76.25% | 78.93% |
Operating Margin | -14.48% | -20.81% | -45.35% | -40.16% | -53.85% | -49.83% |
Profit Margin | -19.62% | -26.15% | -58.36% | -42.31% | -56.99% | -56.39% |
Free Cash Flow Margin | -7.25% | -14.20% | -43.35% | -48.22% | -52.15% | -54.84% |
EBITDA | -19.26 | -27.63 | -31.98 | -26.74 | -33.56 | -26.55 |
EBITDA Margin | -12.42% | -18.52% | -42.70% | -37.48% | -51.47% | -48.01% |
D&A For EBITDA | 3.2 | 3.41 | 1.98 | 1.92 | 1.55 | 1.01 |
EBIT | -22.46 | -31.04 | -33.96 | -28.65 | -35.11 | -27.56 |
EBIT Margin | -14.48% | -20.81% | -45.35% | -40.16% | -53.85% | -49.83% |
Revenue as Reported | 155.1 | 149.16 | 74.89 | 71.35 | - | - |